Heterocyclyl-3-sulfonylazaindole or - azaindazole derivatives as 5-Hydroxytryptamine-6 ligands

Details for Australian Patent Application No. 2004213375 (hide)

Owner Wyeth

Inventors Yan, Yinfa; Bernotas, Ronald Charles

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004213375

PCT Pub. Number WO2004/074286

Priority 60/447,515 14.02.03 US

Filing date 10 February 2004

Wipo publication date 2 September 2004

International Classifications

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 031/395 - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61P 025/00 Drugs for disorders of the nervous system

Event Publications

1 September 2005 PCT application entered the National Phase

  PCT publication WO2004/074286 Priority application(s): WO2004/074286

3 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004213382-Dry paint transfer laminate

2004213374-Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands